Terms: = Gastric cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
4 results:
1. Margetuximab: First Approval.
Markham A
Drugs; 2021 Apr; 81(5):599-604. PubMed ID: 33761116
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan.
Irino T; Sano T; Hiki N; Ohashi M; Nunobe S; Kumagai K; Ida S; Yamaguchi T
Surg Endosc; 2018 Jan; 32(1):268-275. PubMed ID: 28664424
[TBL] [Abstract] [Full Text] [Related]
3. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
[TBL] [Abstract] [Full Text] [Related]
4. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract] [Full Text] [Related]
